Related Experiment Video
Updated: Sep 2, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
COVID-19 induced Diabetes: A novel presentation
Samruddhi Chandrashekhar Joshi1, Paolo Pozzilli2
1Barts and The London School of Medicine and Dentistry, Queen Mary, University of London, UK.
COVID-19 can cause new-onset diabetes, even in individuals without prior risk factors. This novel form of diabetes, termed COVID-induced diabetes, is linked to higher mortality rates and requires early detection and further study.
Area of Science:
- Endocrinology
- Virology
- Metabolic Diseases
Background:
- The COVID-19 pandemic has highlighted unique health challenges, including its impact on patients with pre-existing diabetes.
- A novel phenomenon, COVID-induced diabetes, has been observed, particularly in critically ill patients.
Observation:
- COVID-19 infection can lead to dysregulation of glucose homeostasis, resulting in new-onset diabetes and hyperglycemia.
- This presentation occurs even in individuals without previous risk factors for diabetes mellitus.
- Atypical glycemic parameters and increased diabetic ketoacidosis rates suggest a distinct form of diabetes.
Findings:
- COVID-induced diabetes is associated with significantly higher mortality rates and worse outcomes compared to COVID-19 patients with pre-existing diabetes.
- Potential pathophysiological mechanisms include SARS-CoV-2-induced beta cell damage and insulin resistance.
- A spectrum of COVID-induced diabetes presentations has been noted.
Implications:
- Early detection of COVID-induced diabetes is crucial for improving patient prognosis.
- Further research is needed to understand the long-term trajectory and optimal management strategies.
- Assessing beta cell function and insulin resistance over time is essential for elucidating underlying mechanisms.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...

